Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial

Michael Weller(University of Zurich), Nicholas Butowski(University of California, San Francisco), David Tran(Washington University in St. Louis), Lawrence D. Recht(Stanford Medicine), Michael Lim(Johns Hopkins Hospital), Hal W. Hirte(Juravinski Cancer Centre), Lynn S. Ashby(Barrow Neurological Institute), Laszlo Mechtler(Dent Neurologic Institute), Samuel Goldlust(Hackensack University Medical Center), Fábio M. Iwamoto(Columbia University Irving Medical Center), Jan Drappatz(University of Pittsburgh Medical Center), Donald M. O’Rourke(University of Pennsylvania), Mark Wong(Westmead Hospital), Mark G. Hamilton(University of Calgary), Gaetano Finocchiaro(Fondazione IRCCS Istituto Neurologico Carlo Besta), James Perry(Sunnybrook Health Science Centre), Wolfgang Wick(German Cancer Research Center), Jennifer Green(Celldex Therapeutics (United States)), Yi He(Celldex Therapeutics (United States)), Christopher D. Turner(Celldex Therapeutics (United States)), Michael Yellin(Celldex Therapeutics (United States)), Tibor Keler(Celldex Therapeutics (United States)), Thomas A. Davis(Celldex Therapeutics (United States)), Roger Stupp(University of Zurich), John H. Sampson(Duke Medical Center), Nicholas Butowski(University of California, San Francisco), Jian Campian, Lawrence D. Recht(Stanford Medicine), Michael Lim(Johns Hopkins Hospital), Lynn S. Ashby(Barrow Neurological Institute), Jan Drappatz(University of Pittsburgh Medical Center), Hal W. Hirte(Juravinski Cancer Centre), Fábio M. Iwamoto(Columbia University Irving Medical Center), Laszlo Mechtler(Dent Neurologic Institute), Samuel Goldlust(Hackensack University Medical Center), Kevin Becker, Gene H. Barnett, Garth Nicholas(University of California, San Francisco), Annick Desjardins, Tara Benkers, Naveed Wagle, Morris D. Groves, Santosh Kesari, Zsolt Horváth, Ryan Merrell, Richard Curry, James O’Rourke(University of Pennsylvania), David M. Schuster(Washington University in St. Louis), Mark Wong(Westmead Hospital), Maciej M. Mrugała, Randy Jensen, John Trusheim(Duke Medical Center), Glenn J. Lesser, Karl Bélanger, Andrew E. Sloan, Benjamin Purow, Karen Fink, Jeffrey J. Raizer, Michael Schulder(Celldex Therapeutics (United States)), Suresh Nair, Scott Peak, James Perry(Sunnybrook Health Science Centre), Alba A. Brandes, Michael Weller(University of Zurich), Nimish Mohile, Joseph Landolfi, Jon Olson, Gaetano Finocchiaro(Fondazione IRCCS Istituto Neurologico Carlo Besta), Ross Jennens, Paul DeSouza, Bridget A. Robinson, Marka R. Crittenden, Kent C. Shih, Alexandra Flowers, Shirley Ong(Westmead Hospital), Jennifer Connelly(Celldex Therapeutics (United States)), Costas G. Hadjipanayis, Pierre Giglio, Frank E. Mott, David Mathieu(Washington University in St. Louis), N. Lessard, Sanchez Juan Sepulveda, József Lövey, Helen Wheeler, Po-Ling Inglis, Claire Hardie, Daniela A. Bota, Maciej S. Lesniak, Jana Portnow, Bruce Frankel, Larry Junck, Reid C. Thompson, Lawrence Berk(Stanford Medicine), John Paul McGhie(Duke Medical Center), David Macdonald(Washington University in St. Louis), Frank Saran, Riccardo Soffietti, Deborah T. Blumenthal, Sá Barreto Costa Marcos André de, Anna K. Nowak, Nimit Singhal, Andreas F. Hottinger, Andrea Schmid, Gordan Srkalović, David S. Baskin(Washington University in St. Louis), Camilo E. Fadul, Burt Nabors, Renato V. LaRocca, John L. Villano(Duke Medical Center), Nina A. Paleologos, Petr Kavan, Marshall Pitz, Brian Thiessen, Ahmed Idbaïh, Jean‐Sébastien Frenel, Julien Dômont, Oliver Grauer, Peter Hau, Christine Marosi, Jan Šroubek(University of Pittsburgh Medical Center), Elizabeth Hovey, P.S. Sridhar(Duke Medical Center), Lawrence Cher(Stanford Medicine), Erin Dunbar, Thomas Coyle(Celldex Therapeutics (United States)), Jane M. Raymond, Kevin Barton, Michael J. Guarino(Celldex Therapeutics (United States)), Sumul Raval, Baldassarre Stea, J. Richard Dietrich, Kirsten Hopkins, Sara Erridge, Joachim-Peter Steinbach, Losada Estela Pineda, Quintero Carmen Balana, Barco Berron Sonia del, M. Wenczl, Katalin Molnár, Katalin Hidéghety, Alexander Lossos, Linde Myra van, Ana Levy, Rosemary Harrup, William P. Patterson, Zarnie Lwin, Sith Sathornsumetee, E-Jian Lee, Jih-Tsun Ho(Celldex Therapeutics (United States)), Steven Emmons, J. Paul Duic, Spencer H. Shao, Hani Ashamalla, Michael Weaver(Celldex Therapeutics (United States)), Jose Lutzky, Nicholas G. Avgeropoulos(University of California, San Francisco), Wahid T. Hanna, Mukund Nadipuram, G Cecchi, Robert D. O’Donnell, Susan C. Pannullo, Jennifer Carney(Celldex Therapeutics (United States)), Mark Hamilton(University of Calgary), Mary MacNeil, R. P. Beaney, Michel Fabbro, Oliver Schnell, Rainer Fietkau, Guenther Stockhammer, Běla Malinová, Karel Odrážka, Martin Sameš, Gil Miguel Gil, E. Razis, Konstantin Lavrenkov, Guillermo Castro, Francisco Ramirez, Clarissa Baldotto, Fabiana Viola, Suzana Mária Fleury Malheiros, Jason D. Lickliter, Stanislaw J. Gauden, Arunee Dechaphunkul, Iyavut Thaipisuttikul, Ziad Thotathil, Hsin‐I Ma(Celldex Therapeutics (United States)), Wen-Yu Cheng, Chin-Hong Chang, Fernando Palacios Salas, Pierre‐Yves Dietrich, Christoph Mamot(Celldex Therapeutics (United States)), Lakshmi Nayak, Shona Nag
The Lancet Oncology
August 22, 2017
Cited by 1,105Open Access

Abstract


Related Papers

No related papers found

Powered by citation graph analysis